🇺🇸 FDA
Patent

US 7229770

YKL-40 as a marker and prognostic indicator for cancers

granted A61KA61K2039/505A61P

Quick answer

US patent 7229770 (YKL-40 as a marker and prognostic indicator for cancers) held by The Regents of the University of California expires Mon Jun 07 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 12 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 07 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K2039/505, A61P, A61P19/02, A61P31/00